Mather Group’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
Mather Group's ROIV Position: Q3 2026 in Review
Mather Group opened a new position in Roivant Sciences (ROIV) in Q3 2026: 145 shares worth $5.3K. The stake represents ﹤0.01% of the portfolio and ranks #1802 among its holdings. This is a return to the name: Mather Group previously reported a position in ROIV as recently as Q4 2024.
Mather Group first reported a position in ROIV in Q4 2024 and has held it in 2 quarters since. 93 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.
- Mather Group held 145 shares of Roivant Sciences worth $5.3K as of Q3 2026.
- Roivant Sciences was a new Mather Group position in Q3 2026.
- Roivant Sciences made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #1802 holding.
- Mather Group first reported a position in Roivant Sciences in Q4 2024 and has held it in 2 quarters since.
- 93 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.
Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.